Journal of Pharmaceutical Practice and Service 2022;40(5):416-421

doi:10.12206/j.issn.2097-2024.202110042

Research progress of atorvastatin gene polymorphism

Qin HUANG 1 ; Gele SUONAN 2 ; Wenbin LI 3 ; Yuemei SUN 3 ; Rong WANG 1

Affiliations

+expand

Keywords

atorvastatin; blood lipids; drug metabolizing enzymes; drug transporters; gene polymorphisms

Country

China

Language

Chinese

Abstract

Atorvastatin is a blood lipid-lowering drug widely used clinically. Long-term use can prevent and reduce the occurrence of atherosclerotic cardiovascular disease (ASCVD). However, the efficacy of atorvastatin has significant inter-individual differences. Some individuals failed to achieve the expected lipid-lowering target value or had serious adverse reactions, which were related to the genetic diversity between individuals. Genetic variation can lead to differences in drug configuration, clinical efficacy and adverse reactions. The drug metabolism enzymes, drug transporters, drug targets and genetic polymorphisms related to lipid metabolism were reviewed in this paper that affect the drug response of atorvastatin, and from the gene level to explore the reasons for the differences in the pharmacokinetics, pharmacodynamics and susceptibility to adverse reactions of different individuals using atorvastatin.